| Oncogenic role of THOR, a conserved cancer/testis long non-coding RNA Y Hosono, YS Niknafs, JR Prensner, MK Iyer, SM Dhanasekaran, ... Cell 171 (7), 1559-1572. e20, 2017 | 238 | 2017 |
| Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression Y Zhang, S Pitchiaya, M Cieślik, YS Niknafs, JCY Tien, Y Hosono, MK Iyer, ... Nature genetics 50 (6), 814-824, 2018 | 219 | 2018 |
| Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19 C Mirabelli, JW Wotring, CJ Zhang, SM McCarty, R Fursmidt, CD Pretto, ... Proceedings of the National Academy of Sciences 118 (36), e2105815118, 2021 | 213 | 2021 |
| Targeting the MLL complex in castration-resistant prostate cancer R Malik, AP Khan, IA Asangani, M Cieślik, JR Prensner, X Wang, MK Iyer, ... Nature medicine 21 (4), 344-352, 2015 | 212 | 2015 |
| FOXQ1 regulates epithelial-mesenchymal transition in human cancers Y Qiao, X Jiang, ST Lee, RKM Karuturi, SC Hooi, Q Yu Cancer research 71 (8), 3076-3086, 2011 | 207 | 2011 |
| Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer L Xiao, A Parolia, Y Qiao, P Bawa, S Eyunni, R Mannan, SE Carson, ... Nature 601 (7893), 434-439, 2022 | 203 | 2022 |
| The central role of EED in the orchestration of polycomb group complexes Q Cao, X Wang, M Zhao, R Yang, R Malik, Y Qiao, A Poliakov, AK Yocum, ... Nature communications 5 (1), 3127, 2014 | 196 | 2014 |
| Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2 Y Qiao, XM Wang, R Mannan, S Pitchiaya, Y Zhang, JW Wotring, L Xiao, ... Proceedings of the National Academy of Sciences 118 (1), e2021450118, 2021 | 189 | 2021 |
| Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression ZL Wu, SS Zheng, ZM Li, YY Qiao, MY Aau, Q Yu Cell Death & Differentiation 17 (5), 801-810, 2010 | 142 | 2010 |
| Development of peptidomimetic inhibitors of the ERG gene fusion product in prostate cancer X Wang, Y Qiao, IA Asangani, B Ateeq, A Poliakov, M Cieślik, S Pitchiaya, ... Cancer cell 31 (4), 532-548. e7, 2017 | 116 | 2017 |
| Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage Z Wu, ST Lee, Y Qiao, Z Li, PL Lee, YJ Lee, X Jiang, J Tan, M Aau, ... Cell Death & Differentiation 18 (11), 1771-1779, 2011 | 107 | 2011 |
| Protein tyrosine phosphatase UBASH3B is overexpressed in triple-negative breast cancer and promotes invasion and metastasis ST Lee, M Feng, Y Wei, Z Li, Y Qiao, P Guan, X Jiang, CH Wong, K Huynh, ... Proceedings of the National Academy of Sciences 110 (27), 11121-11126, 2013 | 82 | 2013 |
| Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer Y Qiao, JE Choi, JC Tien, SA Simko, T Rajendiran, JN Vo, AD Delekta, ... Nature cancer 2 (9), 978-993, 2021 | 81 | 2021 |
| Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer Q Liu, G Wang, Q Li, W Jiang, JS Kim, R Wang, S Zhu, X Wang, L Yan, ... International journal of cancer 145 (2), 415-426, 2019 | 66 | 2019 |
| Epigenetic reprogramming with antisense oligonucleotides enhances the effectiveness of androgen receptor inhibition in castration-resistant prostate cancer L Xiao, JC Tien, J Vo, M Tan, A Parolia, Y Zhang, L Wang, Y Qiao, ... Cancer research 78 (20), 5731-5740, 2018 | 51 | 2018 |
| VSTM2A overexpression is a sensitive and specific biomarker for mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney L Wang, Y Zhang, YB Chen, SL Skala, HA Al-Ahmadie, X Wang, X Cao, ... The American journal of surgical pathology 42 (12), 1571-1584, 2018 | 50 | 2018 |
| Wnt signaling drives prostate cancer bone metastatic tropism and invasion Y Wang, U Singhal, Y Qiao, T Kasputis, JS Chung, H Zhao, F Chammaa, ... Translational oncology 13 (4), 100747, 2020 | 46 | 2020 |
| Multigene profiling of CTCs in mCRPC identifies a clinically relevant prognostic signature U Singhal, Y Wang, J Henderson, YS Niknafs, Y Qiao, A Gursky, ... Molecular Cancer Research 16 (4), 643-654, 2018 | 35 | 2018 |
| Circulating tumor cell–based molecular classifier for predicting resistance to abiraterone and enzalutamide in metastatic castration-resistant prostate cancer JS Chung, Y Wang, J Henderson, U Singhal, Y Qiao, AB Zaslavsky, ... Neoplasia 21 (8), 802-809, 2019 | 34 | 2019 |
| Mechanistic support for combined MET and AR blockade in castration-resistant prostate cancer Y Qiao, FY Feng, Y Wang, X Cao, S Han, K Wilder-Romans, NM Navone, ... Neoplasia 18 (1), 1-9, 2016 | 27 | 2016 |